Ignite Creation Date:
2024-10-26 @ 3:36 PM
Last Modification Date:
2024-10-26 @ 3:36 PM
Study NCT ID:
NCT06522919
Status:
NOT_YET_RECRUITING
Last Update Posted:
None
First Post:
2024-07-09
Brief Title:
Sequential Immunochemotherapy Treatment With Pembrolizumab Plus Dendritic Cell DC Vaccine Followed by TrifluridineTipiracil Plus Bevacizumab in Refractory Mismatch-repair-proficient pMMR or Microsatellite-stable MSS Metastatic Colorectal Cancer
Sponsor:
Organization:
None